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Abstract
The establishment of patient-specific histocompatible stem cells may be an alternative for overcoming current
limitations in stem cell engineering. We are developing an animal model to assist the establishment of
histocompatible, autologous stem cells. In this process, we obtained valuable information on establishing and
characterizing stem cells. As an initial step, we succeeded in establishing histocompatible stem cells using preantral
follicle cultures and subsequent parthenogenetic activation. The gene expression profile of the established stem
cells was similar to that of embryonic stem cells (ESCs) derived from normal fertilization. On the other hand, we
propose a way to derive histocompatible, ESC-like cells by co-culturing ovarian stromal cells with feeder fibroblasts,
which may allow the derivation of stem cells from somatic tissue. However, more progress regarding the
establishment and elucidation on origination of established cell lines is necessary to use this genetic manipulation-
free procedure. Nevertheless, relevant information on the process will help to stimulate preclinical research on cell
transformation into differentiated, undifferentiated, and even cancerous cells, as well as clinical studies on the
application of induced pluripotent cells.
Background
There are several limitations to the use of stem cell
engineering and stem cell-derived biomaterials for thera-
peutic purposes. The establishment of histocompatible
or immune-specific stem cells for a patient is a prere-
quisite for developing stem cell engineering beyond its
present limitations [1]. The development of an effective
method for allowing differentiation into target cells
would contribute greatly to facilitating stem cell engi-
neering for cell therapy. Furthermore, the optimization
of stem cell transplantation techniques and the develop-
ment of a way to effectively regain normal function after
stem cell transplantation are the final requirements for
the cell therapy. From a different perspective, ethical,
legal, and social considerations regarding stem cell
technology will inevitably influence the development of
clinically friendly stem cell engineering.
Methods
We have focused on developing advanced technology for
establishing histocompatible stem cells. A series of stu-
dies to develop novel stem cell engineering approaches
arose from our failure to establish genetically stable
embryonic stem cells (ESCs) upon the interspecies
nuclear transfer of human somatic cells into bovine enu-
cleated oocytes [2]. In fact, somatic cell nuclear transfer
technology cannot guarantee complete cloning due to
the presence of mitochondrial DNA [3], which causes
phenotypic heterogeneity. In addition, there is a huge
oocyte reservoir in the ovaries, with each ovary posses-
sing approximately one million preantral (primordial,
primary, and secondary stages) follicles. In various spe-
cies, most preantral follicles are not mobilized to derive
viable oocytes throughout the lifetime of the organism
because of spontaneous degeneration. Given this
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ogy that combines in vitro folliculogenesis and parthe-
nogenesis to establish histocompatible stem cells.
As another approach, we attempted to derive histo-
compatible stem cells from terminally differentiated tis-
sue. To derive the stem cells, we examined various cell
niches involving feeder cells and the stromal cell popu-
lation, which potentially includes stem cells or their pro-
genitor cells. The success of this approach enormously
expands the feasibility of stem cell engineering for both
preclinical research and clinical application. In addition,
valuable information on cell transformation into differ-
entiated, undifferentiated, and even cancerous cells can
be obtained from this cell transformation model.
Results
Information from follicle cultures and oocyte
parthenogenesis
At any given time, numerous preantral follicles are pre-
sent at different stages in mammalian ovaries. Through-
out a woman’s life, less than 0.1% of immature follicles
develop to the mature stage capable of yielding develop-
mentally competent oocytes [4]. The others either disap-
pear after birth or remain in a ‘developmentally
dormant’ state in the ovarian cortex or medullary tissues
[5]. Theoretically, many immature follicles can be used
to derive developmentally competent oocytes, which
could be linked to establish histocompatible (autolo-
gous) stem cells following parthenogenetic activation.
Using this strategy, the abuse of viable oocytes derived
from normal folliculogenesis and natural ovulation can
be avoided, although the cloning of oocyte donors can-
not be completely eliminated. We subsequently elabo-
rated on the culturing of preantral follicles for deriving
developmentally competent oocytes.
As the first step in establishing a follicle culture, we
used neonatal mice as follicle donors, in order to
retrieve a large number of preantral follicles [6]. The fol-
licles were retrieved mechanically, without enzyme treat-
ment, to prevent the cellular damage caused by enzyme
treatment and thus improve follicle development [7-9].
The retrieved follicles were washed three times and cul-
tured singly in 20-μl culture droplets [7,10]. Of the
t h r e es t a g e so fi m m a t u r ef o l l i c l e s ,w eu s e dp r i m a r yo r
early secondary follicles for in vitro culture. Either a-
minimal essential medium or Dulbecco’sm o d i f i e d
Eagle’s medium (DMEM) was used as the basal medium
[6,7,10-13], and serum, growth factors, antibiotics, and
other substances were added. In particular, various
amounts of follicle-stimulating hormone and luteinizing
hormone were added to the culture medium because of
their importance in follicle growth and oocyte matura-
tion [13-17]. The duration of in vitro culture is an
important factor for enabling the full development of
preantral follicles. Primary follicles were cultured for 11
days, and early secondary follicles were cultured for 9
days [7,10]. For the parthenogenetic activation of
oocytes derived from the follicle culture, we selected a
treatment using Ca
2+-free KSOM medium supplemented
with SrCl2 and cytochalasin B. To derive colony-forming
cells from parthenogenetic blastocysts, inner cell mass
(ICM) cells of a blastocyst attaching to the feeder cell
were isolated and subcultured. When the attached ICM
cells were stably maintained as colony-forming cells,
their stem cell nature was evaluated using a variety of
markers, assays, and differentiation techniques.
A number of stem cell lines have been derived from
follicle cultures, and the original system has been opti-
mized by adding or deleting specific factors. To assess
the clinical usefulness of our technology, it was impor-
tant to determine whether the parthenogenetic stem
cells had a potential for self-renewal and differentiation
as well as physiological and genetic properties that were
similar to those of normally fertilized stem cells or
reported ESCs. The gene expression profiles of two
parthenogenetic ESC lines were compared with those of
two normally fertilized ESC lines using genome-wide
microarray analysis [18]. The mRNA expression levels
were quantified to validate the data. As shown in Fig 1,
in two comparisons, i.e., one for each parthenogenetic
ESC line, the reactions of 11,347 and 15,454 gene
probes, respectively, were altered by parthenogenesis,
while strain differences accounted for changes in the
reactions of 15,750 and 14,944 probes. The correlation
coefficient was higher for the comparisons between nor-
mally fertilized and parthenogenetic ESCs than for the
comparisons between strains of normally fertilized ESCs.
The expression levels of approximately 3,300 genes were
changed after parthenogenesis, and about 90% of the
major functional genes differentially expressed in one
comparison set showed the same difference in the other
comparison. The expression levels of several paternally
and maternally imprinted genes were also altered after
parthenogenesis, and the differentially expressed genes
were similar for each comparison. Thus, although
altered expression of some genes was observed in ESCs
after parthenogenesis, the degree of alteration was simi-
lar to or less than that observed between ESC strains of
the same derivation in a given genetic environment.
Further information on cell differentiation and genetic
stability in vivo after transplantation, as well as in vitro,
is needed to confirm the clinical feasibility of our
system.
The establishment of supportive programs will contri-
bute to increasing the clinical applicability of the follicle
culture system in reproductive biotechnology and infer-
tility medicine, as well as in stem cell engineering. To
date, we have succeeded in deriving developmentally
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Page 2 of 6Figure 1 Comparison of the gene expression profiles of embryonic stem cells (ESCs) derived from different origins. Two sets (A and B)
of comparisons were made using two lines of parthenogenetic ESCs (pESC-1 and pESC-2 for A and B, respectively). In each set, the gene
expression profile of normally fertilized ESCs (nfESCs) derived from R1 strain was first compared with the profile of nfESCs derived from B6D2F1
strain. Comparisons were subsequently made between pESCs and nfESCs of the same strain (B6D2F1) and between pESCs and nfESCs of a
different strain (R1). In the first comparison (A), the change in gene expression after parthenogenesis was less than the change attributable to
the strain difference; the number of genes with altered expression was similar among all comparisons in the second set (B). (Reprinted with
permission from Gong et al., Hum Reprod 2009; 24: 815-814).
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retrieved from the ovaries of adults [19] and the elderly
[20]. The culture of primary follicles can produce devel-
opmentally competent oocytes [21]. An ovarian tissue
bank has been established using an optimized cryopre-
servation protocol [22, 23].
Information from cultures of different cell types for
deriving histocompatible stem cells
In another approach, we endeavored to derive autolo-
gous stem cells by culturing somatic cells. To induce
cell transformation into stem cells, we co-cultured ovar-
ian stromal cells and fetal fibroblasts. This was sug-
gested by a recent report on the presence of tissue-
specific stem cells in non-germline ovarian cells [24].
Germline stem cells have also been identified in adult
ovaries [25, 26]. Ovarian stromal cells include blood and
blood vessel cells, connective tissue cells consisting of
mesenchymal cells, nerve cells, secreting cells, and pri-
mordial germ cells, and it is highly possible that various
types of mesenchymal cells are mixed with fetal fibro-
blasts. Although only a crude design was proposed, the
co-culture of ovarian stromal cells with embryonic fibro-
blasts increased the possibility of inducing stem cell
transformation by cell-to-cell interactions among co-
existing cells. In fact, stem cells and their extracts have
been shown to stimulate the transformation of termin-
ally differentiated cells into stem cells [27, 28]. By utili-
zation of cell-to-cell interaction, we did not employ
genetic manipulation for stem cell establishment in
order to increase the clinical practicality of the proposed
cell transformation system.
We first surveyed the expression of stemness-related
genes in individual ovaries of different animals. Every
ovary expressed Oct-4, Cripto, Rex-1, Dnmt3b, Tert, and
Lif R,a n da l lb u to n ea l s oe x p r e s s e dNanog.H o w e v e r ,
fetal fibroblasts did not show strong signals for stem-
ness-related gene expression, demonstrating that an
extremely small number of the cells expressing stem-
ness-related genes are present among fetal fibroblasts.
Consequently, ovarian stromal cells were pre-filtered
with a cell strainer to dissociate ovarian cells less than
40 μm in diameter, in order to eliminate growing
oocytes and most primary and early secondary follicles
from a mixed cell population. The dissociated cells were
co-cultured with fetal fibroblasts in DMEM-based med-
ium, and two lines of colony-forming cells were derived
from the culture [29]. These colony-forming cells were
morphologically similar to reported ESCs. Both colony-
forming cell lines were continuously maintained in cul-
ture and remained positive for stem cell-specific mar-
kers; stem cell-associated genes were expressed in the
cell lines, with a high level of telomerase activity. Both
lines had a normal diploid karyotype, with XX sex
chromosomes. Markers of germline or ovarian follicular
cells were not detectable in these cell lines. After culture
in leukemia inhibitory factor-free medium, the estab-
lished cells formed embryoid bodies. After subcutaneous
transplantation into NOD-SCID mice, the injected cells
formed teratomas consisting of cells derived from the
three germ layers; however, they failed to induce germ-
line transmission in a limited number of attempts.
To further understand the origin and genetic charac-
teristics of the two colony-forming cell lines, we con-
ducted a short tandem repeat microsatellite analysis,
which showed that the two colony-forming cell lines
were an identical match to the ovary donor. Further-
more, we performed single nucleotide polymorphism
genotyping and methylation analysis of the cell lines,
to determine their origin. Homozygotic and heterozy-
gotic chromosome recombinations were detected in
both the colony-forming cell lines and the parthenoge-
netic ESC lines. The ESCs of the F1 strain possessed
only heterozygotic loci, whereas homozygotic recombi-
nation was detected in the fibroblasts of both inbred
strains. In the methylation analysis, No difference in
the methylation of stem cell-related genes (Nanog and
Oct-4) was seen among the parthenogenetic ESCs, nor-
mally fertilized ESCs, and ovarian colony-forming cells,
although there was a significant difference in the
methylation of several imprinted genes between ovar-
ian colony-forming cells and parthenogenetic ESCs
(Fig. 2). Based on these results, we have identified and
characterized a novel colony-forming cell population
that appears to be derived from either cell transforma-
tion accompanying somatic cell reprogramming or
from tissue-specific stem cell-progenitor cell isolation.
Nevertheless, we cannot completely exclude the
tumorigenesis of ovarian somatic cells or parthenoge-
netic cells as possible origins. Further research is
necessary to obtain conclusive results regarding cell
origin and to evaluate the feasibility of clinical and
industrial applications.
Conclusion
We succeeded in deriving autologous stem cells by cul-
turing primary or early secondary follicles followed by
oocyte parthenogenesis. The genetic characteristics of
the follicle culture-derived stem cells produced by
parthenogenetic activation were similar to those of ESCs
produced by normal fertilization. The follicle culture
technique can be used to obtain developmentally com-
petent oocytes from degeneration-fated, preantral folli-
cles, for reproductive purposes. The successful
derivation of histocompatible stem cells from the co-cul-
ture of ovarian tissue cells and fetal fibroblasts will have
a great impact on the generation of patient-specific cells
from stem cells. Further effort, however, is necessary to
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and to elucidate the origin of the established cells.
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